DiscoverMedical News PodcastWhat the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer
What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer

What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer

Update: 2025-10-29
Share

Description

Drs. Waks and Lynce review the PATINA trial, which showed that adding a CDK4/6 inhibitor to HER2-targeted and endocrine therapy improved progression-free survival in triple-positive breast cancer, shaping how this subgroup may be managed.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer

What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer

PeerDirect Publishing